Company: PRTC
Filing Date: 2025-04-30
Form Type: 20-F
Source: 0001782999-25-000005
Chunk: 115

Company: PureTech Health plc
Filing Date: 2025-04-30
Form: 20-F
Item: Item 18
Chunk 115
---

ITEM 18.       FINANCIAL STATEMENTS    
See pages F-1 through F-55 of this annual report on Form 20-F.
Seaport Therapeutics, Inc. was deemed a significant equity investee under Rule 3-09 of Regulation S-X for the period from October 18, 2024 (the date when it deconsolidated from PureTech) through December 31, 2024. As such, the financial statements and related notes of Seaport Therapeutics, Inc. required by Rule 3-09 of Regulation S-X are provided as Exhibit 99.1 to this annual report.